# KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

> **NCT06747416** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Suzhou Alphamab Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Hemophilia a and B

## Interventions

- **DRUG:** KN057

## Key facts

- **NCT ID:** NCT06747416
- **Lead sponsor:** Suzhou Alphamab Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-02
- **Primary completion:** 2026-09-02
- **Final completion:** 2026-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06747416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06747416, "KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06747416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*